Online inquiry

IVTScrip™ mRNA-Human RUNX2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK1519MR)

This product GTTS-WK1519MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the RUNX2 protein. This product can be used in -related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001015051
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification oligo-dT affinity purification
Target Gene
Gene ID 860
UniProt ID Q13950
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human RUNX2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK1519MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK10736MR IVTScrip™ mRNA-Human ADGRE1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ADGRE1
GTTS-WK26199MR IVTScrip™ mRNA-Human ARHGAP4, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ARHGAP4
GTTS-WK9200MR IVTScrip™ mRNA-Human ADAMTS16, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ADAMTS16
GTTS-WK14271MR IVTScrip™ mRNA-Human ACTR2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ACTR2
GTTS-WK13897MR IVTScrip™ mRNA-Human AC133, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA AC133
GTTS-WK8944MR IVTScrip™ mRNA-Human ADGRG6, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADGRG6
GTTS-WK14999MR IVTScrip™ mRNA-Human APBB1IP, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA APBB1IP
GTTS-WK19732MR IVTScrip™ mRNA-Human ANKRD6, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD6
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW